Results 71 to 80 of about 210,319 (212)

On Projection of Costs and Incremental Cost-Effectiveness Ratios: A Data Example [PDF]

International Journal of Health Sciences (IJHS), 2015
Cost and cost-effectiveness analysis has been more and more important to both policy makers and clinicians in assessing health care delivery. The incremental costeffectiveness ratio (ICER) is widely used inpractice to evaluate the relative health benefit of one treatment over another.
openaire   +1 more source

Cost-effectiveness modelling of telehealth for patients with raised cardiovascular disease risk: evidence from a cohort simulation conducted alongside the Healthlines randomised controlled trial [PDF]

, 2016
OBJECTIVES: To investigate the long-term cost-effectiveness (measured as the ratio of incremental NHS cost to incremental quality-adjusted life years) of a telehealth intervention for patients with raised cardiovascular disease (CVD) risk.
Ara, R., Dixon, P., Edwards, L., Foster, A., Hollinghurst, S., Salisbury, C.   +5 more
core   +3 more sources

Does Cost-Effectiveness Analysis Discriminate against Patients with Short Life Expectancy? [PDF]

Does the use of quality-adjusted life-years (QALYs) in cost-effectiveness analyses (CEAs) of health care interventions necessarily discriminate against patients with short life expectancy compared with others?
Anthony J. Culyer, Mike Paulden
core  

Custo-efetividade de estratégias de prevenção contra a leishmaniose tegumentar americana na Argentina [PDF]

, 2013
The aim of this study was to estimate the cost-effectiveness of reducing tegumentary leishmaniasis transmission using insecticide-impregnated clothing and curtains, and implementing training programs for early diagnosis.
Orellano, Pablo Wenceslao, Salomon, Oscar Daniel, Vazquez, Néstor   +2 more
core   +1 more source

A cost utility and cost effectiveness analysis of different oral antiviral medications in patients with HBeAg-Negative chronic hepatitis B in Iran: an economic microsimulation decision model [PDF]

, 2016
Background: Although hepatitis B infection is the major cause of chronic liver disease in Iran, no studies have employed economic evaluations of the medications used to treat Iranian patients with chronic hepatitis B (CHB).
Alavian, Seyed Moayed, Javanbakht, Mehdi, Kebriaeezadeh, Abbas, Keshavarz, Khosro, Keshvari, Maryam, Lotfi, Farhad, Meshkini, Amir Hashemi, Nikfar, Shekoufeh, Rezaei Hemami, Mohsen, Sari, Ali Akbari   +9 more
core   +1 more source

Cost effectiveness of school-located influenza vaccination programs for elementary and secondary school children. [PDF]

, 2019
BackgroundStudies have noted variations in the cost-effectiveness of school-located influenza vaccination (SLIV), but little is known about how SLIV's cost-effectiveness may vary by targeted age group (e.g., elementary or secondary school students), or ...
Albertin, Christina S, Concannon, Cathleen, Goldstein, Nicolas PN, Humiston, Sharon G, Rand, Cynthia M, Schaffer, Stanley J, Szilagyi, Peter G, Yoo, Byung-Kwang   +7 more
core  

Cost-effectiveness Analysis of Nirmatrelvir/Ritonavir Compared with Molnupiravir in Patients at High Risk for Progression to Severe COVID-19 in Japan

Journal of Health Economics and Outcomes Research
# Background Nirmatrelvir/ritonavir (NMV/r) and molnupiravir are oral antiviral drugs approved for the treatment of early symptomatic patients with mild to moderate COVID-19 at high risk of progression to severe disease in Japan.
Akira Yuasa, Hiroyuki Matsuda, Yosuke Fujii, Tendai Mugwagwa, Yuki Kado, Mizuki Yoshida, Koichi Murata, Yoshiaki Gu   +7 more
doaj   +1 more source

Unit costs and cost-effectiveness of a device to improve TB treatment adherence in China

IJTLD Open
BACKGROUND: Adherence to TB drugs is crucial for improving treatment outcomes. Digital adherence technologies can improve adherence; however, there is a lack of evidence on cost-effectiveness.
S. Sweeney, K. Fielding, X. Liu, J.A. Thompson, H. Dong, S. Jiang, Y. Zhao, S. Huan, A. Vassall   +8 more
doaj   +1 more source

Cost-effectiveness of protein-rich meals and snacks for increasing protein intake in older adults

The Journal of Nutrition, Health and Aging
Objectives: To investigate the cost-effectiveness of protein-rich meals and snacks for increasing protein intake in home-dwelling older adults. Design: Cost effectiveness analysis from a randomized controlled trial, the Power Meals study.
P. Rautakallio-Järvinen, S. Kunvik, M. Laaksonen, L. Fogelholm, I. Nykänen, U. Schwab   +5 more
doaj   +1 more source

Acceptable Incremental Cost Effectiveness Ratio for Use of New Drugs, Cases in Statin Therapies

YAKUGAKU ZASSHI, 2010
As it is an urgent issue to contain increasing healthcare expenditures, unlimited reimbursement of pharmaceuticals continues to be controversial. The objective of this study is to identify acceptable incremental cost effectiveness ratios between new and conventional therapies.
Susumu, Nakao, Hiroyuki, Kawabe, Hiroki, Takuma, Makoto, Shiragami   +3 more
openaire   +3 more sources